title: Ascorbic acid for amelioration of reperfusion injury in a lung autotransplantation model in sheep.
abstract: BACKGROUND
  Reperfusion injury is the leading cause of early graft dysfunction after lung transplantation. Activation of neutrophilic granulocytes with generation of free oxygen radicals appears to play a key role in this process. The efficacy of ascorbic acid as an antioxidant in the amelioration of reperfusion injury after lung transplantation has not been studied yet.
  
  
  METHODS
  An in situ autotransplantation model in sheep is presented. The left lung was flushed (Euro-Collins solution) and reperfused; after 2 hours of cold storage, the right hilus was then clamped (group R [reference], n = 6). Group AA animals (n = 6) were treated with 1 g/kg ascorbic acid before reperfusion. Controls (group C, n = 6) underwent hilar preparation and instrumentation only.
  
  
  RESULTS
  In group R, arterio-alveolar oxygen difference (AaDO2) and pulmonary vascular resistance (PVR) were significantly elevated after reperfusion. Five of 6 animals developed frank alveolar edema. All biochemical parameters showed significant PMN activation. In group AA, AaDO2, PVR, work of breathing, and the level of PMN activation were significantly lower.
  
  
  CONCLUSIONS
  The experimental model reproduces all aspects of lung reperfusion injury reliably. Ascorbic acid was able to weaken reperfusion injury in this experimental setup.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University Hospitals, Homburg/Saar, Germany. stef.dem@mailcity.com
authors.forename: S
authors.initials: S
authors.lastname: Demertzis
authors.forename: M
authors.initials: M
authors.lastname: Scherer
authors.forename: F
authors.initials: F
authors.lastname: Langer
authors.forename: A
authors.initials: A
authors.lastname: Dwenger
authors.forename: B
authors.initials: B
authors.lastname: Hausen
authors.forename: H J
authors.initials: HJ
authors.lastname: Schäfers
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D016040:Lung Transplantation; D023421:Models, Animal; D018375:Neutrophil Activation / Q000187:drug effects; D010100:Oxygen / Q000032:analysis; D011652:Pulmonary Circulation / Q000187:drug effects; D015427:Reperfusion Injury / Q000517:prevention & control*; D012756:Sheep; D014182:Transplantation, Autologous; D014655:Vascular Resistance; D014939:Work of Breathing
chemical_list: D000975:Antioxidants; D001205:Ascorbic Acid; D010100:Oxygen